Cargando…

Editorial: The link between metabolic syndrome and chronic kidney disease: Focus on diagnosis and therapeutics

Detalles Bibliográficos
Autores principales:	Hou, Ningning, Luo, Congjuan, Lin, Guiting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516327/ https://www.ncbi.nlm.nih.gov/pubmed/36187127 http://dx.doi.org/10.3389/fendo.2022.1030497

Ejemplares similares

Editorial: Metabolic miscommunication among organs: The missing links
por: Meneses, Maria João, et al.
Publicado: (2023)

Editorial: The link between obesity, type 2 diabetes, and mitochondria
por: Luo, Moulun, et al.
Publicado: (2023)

Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies
por: Ying, Hui, et al.
Publicado: (2023)

Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease
por: Drożdż, Monika, et al.
Publicado: (2023)

Editorial: The Role of Obesity and Metabolic Syndrome in Couple Infertility
por: Marchiani, Sara, et al.
Publicado: (2021)

Editorial: Association of novel anthropometric indexes with metabolic syndrome
por: Khashayar, Patricia, et al.
Publicado: (2022)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
por: Di Pietro, Paola, et al.
Publicado: (2023)

Editorial: Central and peripheral mechanism interfering in metabolic syndrome
por: Quiñones, Mar, et al.
Publicado: (2023)

Editorial: “Linking Hypoxia to Obesity”
por: Foti, Daniela P., et al.
Publicado: (2017)

Myostatin: a potential therapeutic target for metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Editorial: The role of oxidative stress and systemic inflammation in diabetes and chronic kidney disease
por: Chanda, Dipanjan, et al.
Publicado: (2023)

Editorial: Microbiota-hormones-gut axis as a therapeutic target for metabolic disorders
por: Abidi, Anouar, et al.
Publicado: (2023)

Editorial: The role of vitamin D in reducing the risk of metabolic syndromes
por: Al-Oanzi, Ziad H., et al.
Publicado: (2023)

Organotin Compounds Toxicity: Focus on Kidney
por: Barbosa, Carolina Monteiro de Lemos, et al.
Publicado: (2018)

Editorial: Association of novel anthropometric indexes with metabolic syndrome and beyond, volume II
por: Mohammadian Khonsari, Nami, et al.
Publicado: (2023)

Editorial: Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?
por: Wani, Kaiser, et al.
Publicado: (2023)

Shear Wave Elastography in the Diagnosis of Peripheral Neuropathy in Patients With Chronic Kidney Disease Stage 5
por: Li, Xuan, et al.
Publicado: (2022)

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment
por: Huang, Zhe, et al.
Publicado: (2023)

Metabolic Syndrome-Related Kidney Injury: A Review and Update
por: Lin, Lirong, et al.
Publicado: (2022)

Editorial: Cross Talk Between the Immune System and Metabolism
por: Chen, Jie, et al.
Publicado: (2020)

Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
por: Yan, Jiayi, et al.
Publicado: (2022)

Editorial: Circadian Rhythms and Metabolism
por: Challet, Etienne, et al.
Publicado: (2017)

Editorial: Endocrine Disrupters and Metabolism
por: Gibert, Yann, et al.
Publicado: (2019)

Editorial: The metabolic effect of prolactin
por: Krogh, Jesper
Publicado: (2023)

Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome
por: Mir, Fayaz Ahmad, et al.
Publicado: (2022)

Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction
por: Qiu, Shanhu, et al.
Publicado: (2022)

Re-understanding and focusing on normoalbuminuric diabetic kidney disease
por: An, Na, et al.
Publicado: (2022)

Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study
por: Yu, Peng, et al.
Publicado: (2022)

Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
por: Martin, William P., et al.
Publicado: (2020)

Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
por: Dao, Myriam, et al.
Publicado: (2021)

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
por: Qu, Na, et al.
Publicado: (2022)

A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism
por: Duntas, Leonidas H., et al.
Publicado: (2018)

Editorial: Control of Adipocyte Differentiation and Metabolism
por: Capilla, Encarnación, et al.
Publicado: (2015)

Editorial: Developmental Programming of Metabolic Diseases
por: Glastras, Sarah J., et al.
Publicado: (2021)

Editorial: Immune Regulation of Metabolic Homeostasis
por: Guigas, Bruno, et al.
Publicado: (2022)

Editorial: Sphingolipid metabolism dysfunction in cancer
por: El Ridi, Rashika, et al.
Publicado: (2023)

Editorial: Environmental exposomics and metabolic disorders
por: Paulesu, Luana Ricci, et al.
Publicado: (2023)

Editorial: Environmental stressors and metabolic disease
por: Zhang, Kezhong, et al.
Publicado: (2023)

Editorial: Circadian rhythm in metabolism and endocrinology
por: Rodriguez-Fernandez, Maria
Publicado: (2023)

Editorial: Diagnosis, prevention and treatment in diabetic nephropathy
por: Rando, Maria Margherita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86hi0u2plrgtek56shprou8l16